Related Experiment Video

Updated: Aug 12, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

[Clinical and biochemical diagnosis of galactosemia among our cases]

K Bozkowa, E Zbieg-Sendecka, Z Grodzka

    Problemy Medycyny Wieku Rozwojowego
    |January 1, 1979
    PubMed

    Insights

    This study identifies key clinical and biochemical markers for diagnosing galactosemia in infants, emphasizing early detection through newborn screening and family history. Prompt diagnosis and a galactose-free diet are crucial for managing this genetic disorder.

    Area of Science:

    • Biochemistry
    • Genetics
    • Pediatrics

    Context:

    • Galactosemia is a rare genetic disorder affecting infants.
    • Early diagnosis is critical for preventing severe health complications.
    • Newborn screening and family history aid in identifying affected individuals.

    Purpose:

    • To analyze clinical and biochemical findings in 17 galactosemia cases.
    • To evaluate diagnostic methods including enzymatic assays and metabolite levels.
    • To highlight the importance of early detection and management.

    Summary:

    • Seventeen cases of galactosemia from 15 families were diagnosed between 1 day and 11 months of age.
    • Common symptoms include hepatomegaly, jaundice, splenomegaly, vomiting, diarrhea, and cataracts.
    • Biochemical diagnosis confirmed absent galactose-1-phosphate uridyl transferase activity and elevated galactose-1-phosphate levels in red blood cells.

    Impact:

    • Establishes characteristic clinical and biochemical profiles for galactosemia diagnosis.
    • Reinforces the value of newborn screening and family history in early detection.
    • Underscores the necessity of a galactose-free diet for managing galactosemia.

    More Related Videos

    Analysis of Fucosylated Human Milk Trisaccharides in Biotechnological Context Using Genetically Encoded Biosensors10:17

    Analysis of Fucosylated Human Milk Trisaccharides in Biotechnological Context Using Genetically Encoded Biosensors

    Published on: April 13, 2019

    Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model09:44

    Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

    Published on: March 5, 2022

    Related Concept Videos

    Glucose Transporters01:27

    Glucose Transporters

    Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
    Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
    Inborn Errors of Metabolism01:20

    Inborn Errors of Metabolism

    Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
    Serum Laboratory Studies, Stool Test, Breath Test01:30

    Serum Laboratory Studies, Stool Test, Breath Test

    Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
    Type I Diabetes III: Clinical Manifestations01:19

    Type I Diabetes III: Clinical Manifestations

    Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
    Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

    Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

    Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
    Diabetic Ketoacidosis l: Introduction01:25

    Diabetic Ketoacidosis l: Introduction

    DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...